These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1537617)

  • 1. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters.
    Thompson AM; Anderson TJ; Condie A; Prosser J; Chetty U; Carter DC; Evans HJ; Steel CM
    Int J Cancer; 1992 Feb; 50(4):528-32. PubMed ID: 1537617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis for p53 overexpression in human breast cancer.
    Davidoff AM; Humphrey PA; Iglehart JD; Marks JR
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):5006-10. PubMed ID: 2052583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in p53 as potential molecular markers for human breast cancer.
    Runnebaum IB; Nagarajan M; Bowman M; Soto D; Sukumar S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10657-61. PubMed ID: 1961733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.
    Coles C; Thompson AM; Elder PA; Cohen BB; Mackenzie IM; Cranston G; Chetty U; Mackay J; Macdonald M; Nakamura Y
    Lancet; 1990 Sep; 336(8718):761-3. PubMed ID: 1976143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.
    Thompson AM; Crichton DN; Elton RA; Clay MF; Chetty U; Steel CM
    Br J Cancer; 1998 Mar; 77(5):797-800. PubMed ID: 9514060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human breast cancer: frequent p53 allele loss and protein overexpression.
    Singh S; Simon M; Meybohm I; Jantke I; Jonat W; Maass H; Goedde HW
    Hum Genet; 1993 Feb; 90(6):635-40. PubMed ID: 8444469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.
    Varley JM; Brammar WJ; Lane DP; Swallow JE; Dolan C; Walker RA
    Oncogene; 1991 Mar; 6(3):413-21. PubMed ID: 2011397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.
    Chen LC; Neubauer A; Kurisu W; Waldman FM; Ljung BM; Goodson W; Goldman ES; Moore D; Balazs M; Liu E
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3847-51. PubMed ID: 1673792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.
    Thompson AM; Steel CM; Chetty U; Hawkins RA; Miller WR; Carter DC; Forrest AP; Evans HJ
    Br J Cancer; 1990 Jan; 61(1):74-8. PubMed ID: 2137009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
    Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
    Prosser J; Thompson AM; Cranston G; Evans HJ
    Oncogene; 1990 Oct; 5(10):1573-9. PubMed ID: 2250913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
    Moll UM; Riou G; Levine AJ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7262-6. PubMed ID: 1353891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
    Götte K; Riedel F; Neubauer J; Schäfer C; Coy JF; Hörmann K
    Int J Oncol; 2001 Aug; 19(2):331-6. PubMed ID: 11445847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the p53 gene occur in diverse human tumour types.
    Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
    Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
    Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT
    J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
    Thorlacius S; Jonasdottir O; Eyfjord JE
    Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 and 17p allelic loss in colorectal carcinoma.
    Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN
    Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic changes in breast carcinomas in an Icelandic population.
    Eyfjörd JE; Thorlacius S
    Pharmacogenetics; 1992 Dec; 2(6):309-16. PubMed ID: 1306132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.